StageZero Life Sciences Ltd
30.7.2021 01:01:40 CEST | ACCESS Newswire | Press release
TORONTO, ON / ACCESSWIRE / July 29, 2021 / StageZero Life Sciences, Ltd. (TSX:SZLS) ("StageZero" or the "Company"), a healthcare company working to reduce the risk of cancer and other chronic diseases through early detection and intervention, today provided an update on its planned acquisition of Health Clinics Limited. The two companies have made excellent progress on the development of the definitive agreement for the transaction and are close to conclusion. However due to the complexity the companies have agreed to extend the timeframe and exclusivity for its completion to August 14, 2021.
"We continue to make progress on what is a complex, international transaction that will ultimately enable more patients to benefit from our combined strengths," said Chairman and CEO James Howard-Tripp. "Our planned acquisition of Health Clinics Limited promises to be transformative for StageZero and will greatly expand our existing partnership, including the broader use of telehealth capabilities to reach millions of consumers and employers who want to keep themselves and their employees healthy and avert chronic disease."
About StageZero Life Sciences, Ltd.
StageZero Life Sciences is dedicated to the early detection of multiple diseases through whole blood tests. The Company's next-generation test, Aristotle®, is the first-ever multi-cancer panel for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer. StageZero's full service, telehealth platform includes access to physicians and phlebotomists who can prescribe and draw samples for individuals and groups, and the Company operates a CAP accredited and CLIA certified high-complexity reference laboratory in Richmond, Virginia. In addition, leveraging its specialty in polymerase chain reaction (PCR) testing for the early identification of cancer through blood, StageZero also provides both COVID PCR testing (swab and saliva) and blood test analysis (Antibody testing). For more information, please visit www.stagezerolifesciences.com.
Forward-Looking Statements
This press release contains forward-looking statements identified by words such as "expects", "will" and similar expressions, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties that could cause the Company's actual events to differ materially from those projected herein. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements, except as required by law.
For further information please contact:
Rebecca Greco
Investor Relations
Tel: 1-855-420-7140 ext. 1838
rgreco@stagezerols.com
SOURCE: StageZero Life Sciences Ltd
View source version on accesswire.com:
https://www.accesswire.com/657723/StageZero-Life-Sciences-Provides-Update-on-Planned-Acquisition-of-Health-Clinics-Limited
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
POLARIS Laboratories Joins the Dow Coolant Care Network as Testing Provider for DOWFROST Heat Transfer Fluids28.5.2026 15:00:00 CEST | Press release
INDIANAPOLIS, IN / ACCESS Newswire / May 28, 2026 / POLARIS Laboratories® today announced Dow has selected POLARIS Laboratories® as a testing provider for DOWFROST™ LC and HD Heat Transfer Fluids used in advanced cooling systems. This collaboration reinforces Dow's commitment to helping customers move beyond reactive maintenance practices toward proactive, data-driven fluid management. DOWFROST™ Heat Transfer Fluids are engineered to support next-generation data center cooling, including direct-to-chip liquid cooling architectures. Formulated with high-purity propylene glycol and advanced inhibitor technology, these fluids enable efficient heat removal, corrosion protection, and long-term operational stability in high-performance computing environments. To meet thermal demands from Artificial Intelligence (AI) and high-density computing, monitoring liquid cooling fluid is critical to protect uptime, maintain performance and reduce operational risk. The Dow Coolant Care Network integrat
Caldwell Strengthens Financial Services and Fintech Capabilities with Addition of Alex Langridge in London28.5.2026 10:30:00 CEST | Press release
TORONTO, ON AND LONDON, UK / ACCESS Newswire / May 28, 2026 / Retained executive search firm Caldwell (TSX:CWL)(OTCQX:CWLPF) today announced the addition of Alex Langridge as a Partner in the firm's Financial Services Practice. Based in London, Langridge advises clients across financial services and fintech on senior executive and board appointments, succession planning, organizational design, and transformational leadership hiring. Based in London, Alex Langridge joins Caldwell's Financial Services Practice, bringing deep expertise across banking, fintech, insurance, and transformational leadership advisory. Langridge brings more than 20 years of executive search and leadership advisory experience, partnering with banks, insurers, fintechs, and private equity- and venture-backed businesses across the UK and EMEA. He is particularly known for placing P&L, operations, commercial, product, technology, and digital leaders into high-impact transformational roles, as well as for helping cli
Applications are Open for the 2026 Semmelweis-Richter Journalism Award Until June 9th28.5.2026 09:00:00 CEST | Press release
BUDAPEST, HUNGARY / ACCESS Newswire / May 28, 2026 / After the strong success of its first edition, the Semmelweis-Richter Journalism Award returns in 2026. Journalists from eligible European countries are invited to submit entries in two categories: Women's Health and Pharmaceutical Strategies and Innovation, with a special focus on cardiovascular therapies. The application deadline is June 9, 2026, 23:59 CET. The international award was first launched in 2025 by Semmelweis University, Hungary's leading medical and health sciences university, with the support of Gedeon Richter, a Hungary-based, innovation-focused multinational pharmaceutical company. The award aims to recognise high-quality health journalism and its role in informing the public and shaping health-related debate across Europe. The first edition attracted wide international interest, with nearly 70 submissions from more than 20 European countries, including the United Kingdom, Germany, and Russia. Entries were published
Miami Fashion Week Successfully Launches Inaugural Virtual Fashion Awards Gala at Queen Miami Beach27.5.2026 18:00:00 CEST | Press release
A groundbreaking evening celebrating the future of fashion through technology, creativity, and innovation brought together global designers, AI-powered runway premieres, and industry recognition. MIAMI, FL / ACCESS Newswire / May 27, 2026 / Miami Fashion Week (MIAFW) successfully hosted its inaugural Virtual Fashion Awards on May 21, 2026, at Queen Miami Beach, hosted by Emmy Award-Winning Journalist, Lisa Petrillo. The exclusive in-person event welcomed global fashion leaders, designers, and innovators for an evening dedicated to creativity, technology, and the evolving future of fashion. Blending physical and digital experiences, the gala featured both produced and in-development collections, highlighting the fusion of emerging technologies with traditional craftsmanship. A live model showcase complemented the AI-powered virtual runway presentations, creating a fully immersive experience for attendees. Images (Courtesy of Miami Fashion Week): here Official Gala Recap and Virtual Pres
OMP Launches Unison Express to Fast-Track Supply Chain Planning from Ambition to Early Value27.5.2026 15:00:00 CEST | Press release
Ready-to-deploy solution delivers value quickly through proven industry best practices ANTWERPEN, BE / ACCESS Newswire / May 27, 2026 / OMP, a leading provider of AI-powered supply chain planning solutions, today announced the launch of Unison Express - an industry-specific, ready-to-deploy planning offering for mid-market companies looking to move beyond the tools and processes they have outgrown. Unison Express enables teams to realize value quickly while establishing a strong planning foundation that scales with their business over time. From spreadsheets to structured planning Organizations across industries face mounting pressure to modernize supply chain planning. Yet implementation projects can feel long, costly, and difficult to justify, especially when teams still rely on tools and processes they have outgrown, such as spreadsheets, legacy systems, and manual coordination. The result is higher operational risk and slower, less coordinated decision-making. Unison Express bridge
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom